(OII) Oceaneering International - Overview
Stock: ROVs, Umbilicals, Subsea Valves, ROV Tooling, Inspection Services
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 46.2% |
| Relative Tail Risk | -3.96% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.72 |
| Alpha | 5.88 |
| Character TTM | |
|---|---|
| Beta | 1.478 |
| Beta Downside | 2.024 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.84% |
| CAGR/Max DD | 0.31 |
Description: OII Oceaneering International January 13, 2026
Oceaneering International (NYSE: OII) delivers engineered services, products, and robotic solutions across offshore energy, defense, aerospace, manufacturing, and entertainment markets worldwide. Its operations span five segments: Subsea Robotics, Manufactured Products, Offshore Projects Group, Integrity Management & Digital Solutions, and Aerospace & Defense Technologies. Core offerings include remotely operated vehicles (ROVs) for drill support, subsea hardware installation, pipeline inspection, hydrographic surveying, autonomous underwater vehicles, and a suite of subsea connection systems such as umbilicals and control valves. The firm also provides riser-less light-well intervention, diving services, project-management engineering, and digital integrity-management software for the maritime and energy sectors, while supporting U.S. defense and space programs.
Key recent metrics: FY 2023 revenue was approximately $2.4 billion, with a backlog of roughly $1.1 billion, indicating a solid order pipeline. Operating margin hovered near 9%, and cash flow from operations exceeded $300 million, supporting ongoing R&D in autonomous underwater technology. The subsea robotics segment has grown ~12% YoY, driven by higher offshore capex as oil prices rebound above $80 per barrel and by renewed deep-water projects in Brazil and West Africa. Conversely, the segment remains sensitive to macro-level oil-price volatility and to the industry’s gradual shift toward renewable-energy-linked offshore infrastructure.
For a data-rich, quantitative view of OII’s valuation and risk profile, you may find ValueRay’s dedicated OII screen useful.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 232.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.59 > 1.0 |
| NWC/Revenue: 26.09% < 20% (prev 23.48%; Δ 2.61% < -1%) |
| CFO/TA 0.09 > 3% & CFO 228.1m > Net Income 232.2m |
| Net Debt (393.9m) to EBITDA (426.9m): 0.92 < 3 |
| Current Ratio: 1.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (101.1m) vs 12m ago -1.52% < -2% |
| Gross Margin: 20.43% > 18% (prev 0.17%; Δ 2026 % > 0.5%) |
| Asset Turnover: 115.6% > 50% (prev 110.4%; Δ 5.14% > 0%) |
| Interest Coverage Ratio: 11.13 > 6 (EBITDA TTM 426.9m / Interest Expense TTM 29.3m) |
Altman Z'' 5.94
| A: 0.29 (Total Current Assets 1.50b - Total Current Liabilities 763.9m) / Total Assets 2.54b |
| B: 0.69 (Retained Earnings 1.75b / Total Assets 2.54b) |
| C: 0.13 (EBIT TTM 325.8m / Avg Total Assets 2.45b) |
| D: 0.85 (Book Value of Equity 1.39b / Total Liabilities 1.63b) |
| Altman-Z'' Score: 5.94 = AAA |
Beneish M -2.93
| DSRI: 1.01 (Receivables 675.3m/617.5m, Revenue 2.83b/2.60b) |
| GMI: 0.84 (GM 20.43% / 17.26%) |
| AQI: 1.28 (AQ_t 0.09 / AQ_t-1 0.07) |
| SGI: 1.09 (Revenue 2.83b / 2.60b) |
| TATA: 0.00 (NI 232.2m - CFO 228.1m) / TA 2.54b) |
| Beneish M-Score: -2.93 (Cap -4..+1) = A |
What is the price of OII shares?
Over the past week, the price has changed by +5.44%, over one month by +19.67%, over three months by +36.51% and over the past year by +26.78%.
Is OII a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the OII price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 24.5 | -23.9% |
| Analysts Target Price | 24.5 | -23.9% |
| ValueRay Target Price | 36.5 | 13.3% |
OII Fundamental Data Overview February 03, 2026
P/E Forward = 18.7617
P/S = 1.0662
P/B = 3.3417
P/EG = 68.34
Revenue TTM = 2.83b USD
EBIT TTM = 325.8m USD
EBITDA TTM = 426.9m USD
Long Term Debt = 486.0m USD (from longTermDebt, last quarter)
Short Term Debt = 127.4m USD (from shortTermDebt, last quarter)
Debt = 899.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 393.9m USD (from netDebt column, last quarter)
Enterprise Value = 3.41b USD (3.02b + Debt 899.9m - CCE 506.0m)
Interest Coverage Ratio = 11.13 (Ebit TTM 325.8m / Interest Expense TTM 29.3m)
EV/FCF = 30.00x (Enterprise Value 3.41b / FCF TTM 113.7m)
FCF Yield = 3.33% (FCF TTM 113.7m / Enterprise Value 3.41b)
FCF Margin = 4.02% (FCF TTM 113.7m / Revenue TTM 2.83b)
Net Margin = 8.21% (Net Income TTM 232.2m / Revenue TTM 2.83b)
Gross Margin = 20.43% ((Revenue TTM 2.83b - Cost of Revenue TTM 2.25b) / Revenue TTM)
Gross Margin QoQ = 20.56% (prev 21.26%)
Tobins Q-Ratio = 1.34 (Enterprise Value 3.41b / Total Assets 2.54b)
Interest Expense / Debt = 0.11% (Interest Expense 984.0k / Debt 899.9m)
Taxrate = 10.79% (8.62m / 79.9m)
NOPAT = 290.7m (EBIT 325.8m * (1 - 10.79%))
Current Ratio = 1.97 (Total Current Assets 1.50b / Total Current Liabilities 763.9m)
Debt / Equity = 0.99 (Debt 899.9m / totalStockholderEquity, last quarter 907.7m)
Debt / EBITDA = 0.92 (Net Debt 393.9m / EBITDA 426.9m)
Debt / FCF = 3.47 (Net Debt 393.9m / FCF TTM 113.7m)
Total Stockholder Equity = 809.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 9.49% (Net Income 232.2m / Total Assets 2.54b)
RoE = 28.69% (Net Income TTM 232.2m / Total Stockholder Equity 809.3m)
RoCE = 25.15% (EBIT 325.8m / Capital Employed (Equity 809.3m + L.T.Debt 486.0m))
RoIC = 22.48% (NOPAT 290.7m / Invested Capital 1.29b)
WACC = 8.77% (E(3.02b)/V(3.92b) * Re(11.36%) + D(899.9m)/V(3.92b) * Rd(0.11%) * (1-Tc(0.11)))
Discount Rate = 11.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.64%
[DCF Debug] Terminal Value 75.29% ; FCFF base≈116.0m ; Y1≈115.8m ; Y5≈122.2m
Fair Price DCF = 14.77 (EV 1.87b - Net Debt 393.9m = Equity 1.47b / Shares 99.8m; r=8.77% [WACC]; 5y FCF grow -0.77% → 2.90% )
EPS Correlation: 62.13 | EPS CAGR: 43.33% | SUE: -2.11 | # QB: 0
Revenue Correlation: 94.08 | Revenue CAGR: 13.20% | SUE: 2.04 | # QB: 4
EPS next Quarter (2026-03-31): EPS=0.32 | Chg30d=+0.000 | Revisions Net=-2 | Analysts=4
EPS next Year (2026-12-31): EPS=1.79 | Chg30d=+0.007 | Revisions Net=+1 | Growth EPS=-5.8% | Growth Revenue=+2.3%